121411-05-0

Basic information

• Product Name: 2,4-Pentadienoic acid, 5-phenyl-, methyl ester, (2E)-
• CAS NO: 121411-05-0
• Molecular Formula: C12H12O2
• Molecular Weight: 188.226
• Mol File: 121411-05-0.mol

Chemical Properties

• CAS DataBase Reference: 2,4-Pentadienoic acid, 5-phenyl-, methyl ester, (2E)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2,4-Pentadienoic acid, 5-phenyl-, methyl ester, (2E)-(121411-05-0)
• EPA Substance Registry System: 2,4-Pentadienoic acid, 5-phenyl-, methyl ester, (2E)-(121411-05-0)

Safety Data

• Hazardous Substances Data: 121411-05-0(Hazardous Substances Data)

Upstream product

• 104-55-2 3-phenyl-propenal 
• 21204-67-1 methyl (triphenylphosphoranylidene)acetate 
• 103-64-0 bromostyrene 
• 292638-85-8 acrylic acid methyl ester 
• 2136-75-6 (triphenylphosphoranylidene)acetaldehyde 
• 100-51-6 benzyl alcohol 
• 100-42-5 styrene 
• 67-56-1 methanol 
• 139005-35-9 C₁₂H₉O₃^(1-)*K⁽¹⁺⁾ 
• 536-74-3 phenylacetylene 
• 24676-98-0 diethyl 3-methoxycarbonyl-2-propenylidenephosphonate 
• 100-52-7 benzaldehyde 
• 28010-12-0 5-phenylpenta-2,4-dienoic acid 
• 96-32-2 bromoacetic acid methyl ester 

Downstream Products

• 85380-22-9 bis(chloro(η4-methyl-5-phenyl-2,4-pentadienoate)rhodium(I)) 
• 40926-86-1 5-phenyl-penta-2,4-dienoyl chloride 
• 1552-94-9 5-phenyl-2,4-pentadienoic acid 
• 24239-89-2 2,6-diphenyl-3,6-dihydro-2H-[1,2]oxazine-3-carboxylic acid methyl ester 
• 24239-88-1 2,3-diphenyl-3,6-dihydro-2H-[1,2]oxazine-6-carboxylic acid methyl ester 
• 142039-55-2 (2E,4E)-N-benzyl-5-phenyl-2,4-pentadienamide 
• 34271-65-3 (2E,4E)-5-phenylpenta-2,4-dienamide 
• 100-52-7 benzaldehyde 
• 337368-37-3 (4E)-3,5-diphenylpent-4-enoic acid methyl ester 
• 20620-59-1 5-phenyl-n-valeric acid methyl ester 
• 158807-52-4 methyl (3S)-3-(N-tert-butoxycarbonylamino)-5-phenylpentanoate 
• 170726-18-8 methyl (3S)-3-amino-5-phenylpentanoate 
• 368448-99-1 (3R,4E)-3-amino-5-phenylpent-4-enoic acid 
• 368449-00-7 (2S,3S,4E)-3-amino-2-methyl-5-phenylpent-4-enoic acid 

Relevant articles and documents

Non-cross-linked polystyrene-supported triphenylarsonium halides and their use in the arsa-Wittig reaction

Non-cross-linked polystyrene-supported (carbomethoxymethyl) triphenylarsonium bromide (1) and benzyltriphenylarsonium iodide (2) were synthesized. They showed similar reactivities compared with the free arsonium salts in the arsa-Wittig reaction. The use of the polymer-supported reagents facilitated product purification and rendered the organoarsenic reagents easily separable and recyclable.

Visible Light Induced Br?nsted Acid Assisted Pd-Catalyzed Alkyl Heck Reaction of Diazo Compounds and N-Tosylhydrazones

A mild visible light-induced palladium-catalyzed alkyl Heck reaction of diazo compounds and N-tosylhydrazones is reported. A broad range of vinyl arenes and heteroarenes with high functional group tolerance, as well as a range of different diazo compounds, can efficiently undergo this transformation. This method features Br?nsted acid-assisted generation of hybrid palladium C(sp3)-centered radical intermediate, which allowed for new selective C?H functionalization protocol.

Oxoammonium-Mediated Allylsilane–Ether Coupling Reaction

A new C(sp3)?H functionalization reaction consisting of the oxidative α-allylation of allyl- and benzyl- methyl ethers has been developed. The C?C coupling could be carried out under mild conditions thanks to the use of cheap and green oxoammonium salts. The scope of the reaction was studied over 27 examples, considering the nature of the substituents on the two coupling partners.

Ruthenium-Catalyzed Oxidative Cross-Coupling Reaction of Activated Olefins with Vinyl Boronates for the Synthesis of (E, E)-1,3-Dienes

An oxidative cross-coupling reaction between activated olefins and vinyl boronate derivatives has been developed for the highly stereoselective construction of synthetically useful (E,E)-1,3-dienes. The highlight of this reaction is that exclusive stereoselectivity (only E,E-isomer) was achieved from a base-free, ligand-free, and mild catalytic condition with a less expensive [RuCl2(p-cymene)]2 catalyst.

TREATMENT OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS AND COMPOUNDS FOR SAME

The present invention relates to the treatment of disorders associated with oxidative stress including neuropathic pain and small synthetically derived compounds for treating such disorders.

Hydroperoxidations of Alkenes using Cobalt Picolinate Catalysts

Hydroperoxides were synthesized in one step from various alkenes using Co(pic)2as the catalyst with molecular oxygen and tetramethyldisiloxane (TMDSO). The hydration product could be obtained using a modified catalyst, Co(3-mepic)2, with molecular oxygen and phenylsilane. Formation of hydroperoxides occurred through a rapid Co-O bond metathesis of a peroxycobalt compound with isopropanol.

Enantioselective Redox-Divergent Chiral Phosphoric Acid Catalyzed Quinone Diels–Alder Reactions

An efficient enantioselective construction of tetrahydronaphthalene-1,4-diones as well as dihydronaphthalene-1,4-diols by a chiral phosphoric acid catalyzed quinone Diels–Alder reaction with dienecarbamates is reported. The nature of the protecting group on the diene is key to the success of achieving high enantioselectivity. The divergent “redox” selectivity is controlled by using an adequate amount of quinones. Reversible redox switching without erosion of enantioselectivity was possible from individual redox isomers.

Palladium-Catalyzed Regio- A nd Enantioselective Hydrosulfonylation of 1,3-Dienes with Sulfinic Acids: Scope, Mechanism, and Origin of Selectivity

Chiral sulfones are important structural motifs in organic synthesis because of their widespread use in pharmaceutical chemistry. In particular, chiral allylic sulfones have drawn particular interest because of their synthetic utility. However, enantioselective synthesis of 1,3-disubstituted unsymmetrical chiral allylic sulfones remains a challenge. In this article, we report a protocol for (R)-DTBM-Segphos/Pd-catalyzed regio- A nd enantioselective hydrosulfonylation of 1,3-dienes with sulfinic acids, which provides atom- A nd step-economical access to 1,3-disubstituted chiral allylic sulfones. The reaction occurs under mild conditions and has a broad substrate scope. Combined experimental and computational studies suggest that the reaction is initiated by a ligand-to-ligand hydrogen transfer followed by a C-S bond reductive elimination via a six-membered transition state. Steric repulsion between the olefinic C-H of the substrate and the tert-butyl group of (R)-DTBM-Segphos was found to be a key factor in the enantiocontrol.

Developing glutathione-activated catechol-type diphenylpolyenes as small molecule-based and mitochondria-targeted prooxidative anticancer theranostic prodrugs

Developing concise theranostic prodrugs is highly desirable for personalized and precision cancer therapy. Herein we used the glutathione (GSH)-mediated conversion of 2,4-dinitrobenzenesulfonates to phenols to protect a catechol moiety and developed stable pro-catechol-type diphenylpolyenes as small molecule-based prooxidative anticancer theranostic prodrugs. These molecules were synthesized via a modular route allowing creation of various pro-catechol-type diphenylpolyenes. As a typical representative, PDHH demonstrated three unique advantages: (1) capable of exploiting increased levels of GSH in cancer cells to in situ release a catechol moiety followed by its in situ oxidation to o-quinone, leading to preferential redox imbalance (including generation of H2O2 and depletion of GSH) and final selective killing of cancer cells over normal cells, and is also superior to 5-fluorouracil and doxorubicin, the widely used chemotherapy drugs, in terms of its ability to kill preferentially human colon cancer SW620 cells (IC50 = 4.3 μM) over human normal liver L02 cells (IC50 = 42.3 μM) with a favourable in vitro selectivity index of 9.8; (2) permitting a turn-on fluorescent monitoring for its release, targeting mitochondria and therapeutic efficacy without the need of introducing additional fluorophores after its activation by GSH in cancer cells; (3) efficiently targeting mitochondria without the need of introducing additional mitochondria-directed groups.

Gb3 Glycosphingolipids with Fluorescent Oligoene Fatty Acids: Synthesis and Phase Behavior in Model Membranes

Glycosphingolipids are involved in a number of physiological and pathophysiological processes, and they serve as receptors for a variety of bacterial toxins and viruses. To investigate their function in lipid membranes, fluorescently labeled glycosphingolipids are highly desirable. Herein, a synthetic route to access Gb3 glycosphingolipids with fluorescently labeled fatty acids, consisting of pentaene and hexaene moieties either at the terminus or in the middle of the acyl chain, has been developed. The fluorescent properties of the Gb3 derivatives were investigated in small unilamellar vesicles composed of a raft-like mixture. Phase-separated giant unilamellar vesicles (GUVs) allowed the quantification of the apparent partitioning coefficients of the Gb3 compounds by means of confocal fluorescence laser scanning microscopy. The determined partition coefficients demonstrate that the Gb3 derivatives are preferentially localized in the liquid-disordered (ld) phase. To analyze whether the compounds behave like their physiological counterparts, Cy3-labeled (Cy: cyanine) Shiga toxin B subunits (STxB) were specifically bound to Gb3-doped GUVs. However, the protein was favorably localized in the ld phase, in contrast to results reported for STxB bound to naturally occurring Gb3, which is discussed in terms of the packing density of the lipids in the liquid-ordered (lo) phase.